Renal function and bisphosphonate safety

J Bone Miner Res. 2008 Mar;23(3):453-4; author reply 455. doi: 10.1359/jbmr.071028.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alendronate / adverse effects
  • Alendronate / therapeutic use*
  • Bone Density / drug effects
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use*
  • Creatinine / metabolism
  • Female
  • Fractures, Bone / prevention & control*
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Middle Aged
  • Osteoporosis, Postmenopausal / complications*
  • Osteoporosis, Postmenopausal / drug therapy*
  • Osteoporosis, Postmenopausal / physiopathology
  • Renal Insufficiency / complications*
  • Renal Insufficiency / physiopathology

Substances

  • Bone Density Conservation Agents
  • Creatinine
  • Alendronate